In the context of cancer, C3(H2O) has not been evaluated, although, notably, dysregulation of the alternative pathway of complement activation, which can be initiated by C3(H2O), has been demonstrated in several hematological cancers [85]. Here, C3 is linked to hematopoietic and lymphoid cell neoplasm.